This site is intended only for healthcare professionals resident in Egypt
LORBRENA™: a 3rd-generation ALK TKI, designed to address the unmet medical needs2–4
The macrocyclic ring structure of LORBRENA™2
Abbreviations: ALK, Anaplastic lymphoma kinase; CNS, Central nervous system; NSCLC, Non-small cell lung cancer; TKI, Tyrosine kinase inhibitor
Adverse events should be reported. Adverse events can be reported to [email protected]
To access further materials, resources and receive communication about medicines and vaccines promoted by Pfizer.
The product information provided in this site is intended only for Healthcare Professionals of Egypt. The products discussed herein may have different product labeling in different countries.
Copyright © 2023 Pfizer biopharmaceutical LLC. All rights reserved.
These pages are not intended for patients or members of the general public. This portal contains healthcare promotional content.
If you select ""No"", you will be redirected to Pfizer.com, the global Pfoizer websitee.
I confirm that i am a healthcare professional resident in Egypt.